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Abstract. The advent of DNA microarray technology has supplied a large vol-
ume of data to many fields like machine learning and data mining. Intelligent 
support is essential for managing and interpreting this great amount of informa-
tion. One of the well-known constraints specifically related to microarray data 
is the large number of genes in comparison with the small number of available 
experiments. In this context, the ability of design methods capable of overcom-
ing current limitations of state-of-the-art algorithms is crucial to the develop-
ment of successful applications. In this paper we demonstrate how a supervised 
fuzzy pattern algorithm can be used to perform DNA microarray data reduction 
over real data. The benefits of our method can be employed to find biologically 
significant insights relating to meaningful genes in order to improve previous 
successful techniques. Experimental results on acute myeloid leukemia diagno-
sis show the effectiveness of the proposed approach. 
1   Introduction 
Microarrays are one of the latest high-throughput technologies in experimental mo-
lecular biology, which allow monitoring of gene expression for tens of thousands of 
genes in parallel and are already producing huge amounts of valuable data. Analysis 
and handling of such data is becoming one of the major bottlenecks in the utilization 
of this technology. 
One of the major uses of DNA microarray experiments is to attempt to infer mean-
ingful relationships among genes. Up to now, the analysis of DNA microarray data 
has been divided into four main interdependent branches: (i) gene identification, gene 
selection or gene reduction, (ii) clustering or class discovery, (iii) classification or 
class prediction and (iv) biological discovery. Nevertheless, there are two other paral-
lel research areas in DNA microarray analysis: (v) graphical modeling, that allows the 
rapid interactive exploration of gene relationships and (vi) low-level analysis focused 
on providing better readouts and solving the expression level summarization problem. 
In addition, the characteristics of the data gathered from DNA microarray experi-
ments determine which machine learning methods will apply, and can drive the exten-
sion of existing algorithms. 
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The systematic classification of types of tumors is crucial to achieve advances in 
cancer treatment and research. Although clustering is a popular way of analyzing 
data, input space reduction is often the key phase in the building of an accurate classi-
fier [1]. We propose the use of a fuzzy prototype-based method able to perform gene 
selection. In this case, the goal is the identification of a simplified expression profile 
that can be used to identity relevant genes representing each class of cancer. 
This paper describes our initial research in developing a sound method to perform 
gene selection over real data. Section 2 gives an overview of related work, section 3 
explains the proposed algorithm, section 4 introduces the experimental test bed car-
ried out, finally section 5 gives out the results and concluding remarks. 
2   Previous Related Work 
Classical gene selection methods tend to identify differentially expressed genes from 
a set of microarray experiments [2]. These genes are expected to be up- or down-
regulated between healthy and diseased tissues or between different classes. A differ-
entially expressed gene is a gene which has the same expression pattern for all sam-
ples of the same class, but different for samples belonging to different classes. The 
relevance value of a gene depends on its ability to be differentially expressed. How-
ever, a non-differentially expressed gene will be considered irrelevant and will be 
removed from a classification process even though it might well contain information 
that would improve classification accuracy. One way or another, the selected method 
has to pursue two main goals: (i) reduce the cost and complexity of the classifier and 
(ii) improve the accuracy of the model. 
These methods rank genes depending on their relevance for discrimination. Then 
by setting a threshold, one can filter the less relevant genes among those considered. 
As such, these filtering methods may be seen as particular gene selection methods. An 
important task in microarray data analysis is therefore to identify genes, which are 
differentially expressed in this way. Statistical analysis of gene expression data relat-
ing to complex diseases is of course not really expected to yield accurate results. A 
realistic goal is to narrow the field for further analysis, to give geneticists a short-list 
of genes for analysis into which hard-won funds are worth investing.  
The area of gene identification has been addressed by [3] through the utilization of 
information theory. Several methods have been proposed to reduce dimensions in the 
microarray data domain. These works include the application of genetic algorithms 
[4], wrapper approaches [5], support vector machines [6, 7], spectral biclustering [8] 
etc. Other approaches focus their attention on redundancy reduction and feature ex-
traction [9, 10], as well as the identification of similar gene classes making proto-
types-genes [11]. 
3   Gene Selection Using Fuzzy Patterns 
This work proposes a method for selecting genes which is based on the notion of 
fuzzy pattern (see [12, 13] for more details). Briefly, given a set of microarrays which 
are well classified, for each class it can be constructed a fuzzy pattern (FP) from the 
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fuzzy microarray descriptor (FMD) associated to each one of the microarrays. The 
FMD is a comprehensible description for each gene in terms of one from the follow-
ing linguistic labels: LOW, MEDIUM and HIGH. Therefore, the fuzzy pattern is a proto-
type of the FMDs belonging to the same class where the membership criterion of each 
gene to the fuzzy pattern of the class is frequency-based. Obviously, this fact can be 
of interest, if the set of initial observations are labeled with the same kind of cancer. 
The pattern’s quality of fuzziness is given by the fact that the selected labels come 
from the linguistic labels defined during the transformation into FMD of an initial 
observation. Moreover, if a specific label of one feature is very common in all the 
examples belonging to the same class, this feature is selected to be included in the 
pattern . 
procedure DiscriminantFuzzyPatterns (input: ListFP; output: ListDFP) 
{ 
00  begin 
01    initialize_DFP: FP ← ∅ 
02    for each fuzzy pattern FPi ∈ ListFP do 
03      Initialize_DFP: DFPi ← ∅ 
04      for each fuzzy pattern FPj ∈ ListFP and FPi <>FPj do 
05        for each gen g ∈GetGenes(FPi) do 
06          if (g ∈ GetGenes(FPj)) AND 
                 (GetLabel(FPi, g) <> GetLabel(FPj, g)) then 
07                 AddMember(DFPi, Member(FPi, g))  
08      Add_to_List_of_DFP: Add(ListDFP, DFPi) 
09  end. 
} 
Fig. 1. Proposed algorithm for selecting genes 
3.1   Gene Selection Strategy 
The goal of gene selection in this work is to determine a reduced set of genes, which 
are useful to classify new cases within one of the known classes. For each class it is 
possible to compute a fuzzy pattern from the available data. Since each pattern is 
representative of a collection of microarrays belonging to the same class, we can 
assume that the genes included in a pattern, are significant to the classification of any 
novel case within the class associated with that pattern. Now we are interested in 
those genes that allow us to discriminate the new case from one class with regard to 
the others. Here we introduce the notion of discriminant fuzzy pattern (DFP) with 
regard to a collection of fuzzy patterns. A DFP version of a FP only includes those 
genes that can serve to differentiate it from the rest of the patterns. The algorithm 
used to compute the DFP version of each FP in a collection of fuzzy patterns is shown 
in Figure 1.  
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As can be observed from the algorithm, the computed DFP for a specific FP is dif-
ferent depending on what other FPs are compared with it. It’s not surprising that the 
genes used to discern a specific class from others (by mean of its DFP) will be differ-
ent if the set of rival classes also changes. 
4   Case Study: Acute Myeloid Leukemia 
Acute myeloid leukemia (AML) is a heterogeneous group of hematological cancers 
with marked differences in their response to chemotherapy. As in many other human 
cancers, the diagnosis and classification of AML have been based on morphological, 
cytochemical and immunophenotipic features. More recently, genetic features have 
helped to define biologically homogeneous entities within AML as the Acute Promye-
locytic Leukemia (APL). The correlation between morphologic characteristics, ge-
netic abnormalities and prognostic features is very consistent within the APL group, 
whereas is more inconsistent in the remaining AML.  
Bone marrow (BM) samples from 62 adult patients with newly de novo diagnosed 
AML were analyzed. All samples contained more than 80% blast cells. The median 
age was 36 years (range 14-70 years). Patients were classified according to the WHO 
classification into 4 subgroups: a) 10 APL with t(15;17), b) 4 AML with inv(16), c) 7 
acute monocytic leukemias and d) 41 non-monocytic AML without recurrent cytoge-
netic translocations. Each case (microarray experiment) stores 22,283 ESTs corre-
sponding to the expression level of thousands of genes. The data consisted of 
1,381,546 scanned intensities. 
The goal of this study is to characterize the Acute Promyelocytic Leukemia (APL) 
from the non-APL leukemias in terms of the genetic expression profile. As an addi-
tional requirement of this study, the number of selected genes must be the minimum 
(preserving the accuracy of a binary classifier). 
4.1   Methodology 
We are interested in determining a list of significant genes following the method de-
scribed in section 3.1. Firstly, the selected genes can vary widely with the values of 
the parameters Θ and Π, which must be set up in order to compute the fuzzy patterns. 
Several configurations of these parameters have been tested. After some initial ex-
periments, the tested values of parameters Θ and Π are the nine configurations of the 
Cartesian product {0.7, 0.8, 0.9}×{0.55, 0.60, 0.65}. Each configuration has been 
used to select significant genes from the whole data set of microarrays. This is the 
first experiment carried out, herein referred to as EXP#1. 
From a different point of view, the selected genes can be sensible to the specific 
microarrays from they are selected, namely the data sets used to select genes. There-
fore, a second experiment is considered, herein referred to as EXP#2. It has been split 
the original data set in four chunks, following a stratified 4-fold cross validation strat-
egy and then, the nine configurations have been tested. 
In order to summarize the results of the tests, for each experiment (EXP#1 and 
EXP#2), a collection of three lists have been constructed (one list by each one value 
of parameter Π). Inside each list, the selected genes are ordered by the frequency of 
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appearance of this gene in the tests carried out with the same Π parameter, but differ-
ent Θ parameter. Namely, fixed the value of Π, a gene, which appears in the three 
tests (corresponding to the three possible values of Θ), appears before in the list that 
other gene which only appears in one test (of the three possible values). 
Finally, in order to validate the obtained results we perform two different compari-
sons. Firstly, the selected genes by the proposed method are compared with the genes 
selected with the PAM software [14]. Secondly, a classifier is constructed from the 
data resulting of the projection of the original data within the selected features, and its 
accuracy is evaluated over the 4 test sets of the 4-fold cross validation. The selected 
classifier is growing cell structure (GCS) network [15]. Although this ANN is espe-
cially suitable for unsupervised learning, its choice is motivated by its use in current 
work about the same problem in other research tasks. To perform a classification task, 
the GCS simply responds with the majority class of the node that fires the new case. 
More detailed information about this network can be found in [12, 13]. 
Table 1. Selected genes in experiment EXP#1 
Π = 0.55 (filter1.1)  Π = 0.60 (filter1.2) 
μA Probeset Gene tests  μA Probeset Gene tests 
209960_at -- XOH 209960_at -- XOH 
210755_at -- XOH 210755_at -- XOH 
210997_at HGF XOH 210997_at HGF XOH 
220010_at KCNE1L XOH 220010_at KCNE1L XOH 
209560_s_at DLK1 XOH 209560_s_at DLK1 XOH 
203074_at ANXA8 XOH 203074_at ANXA8 -OH 
207781_s_at ZNF6 XOH 205110_s_at FGF13 -OH 
208894_at HLA-DRA XOH     
212187_x_at PTGDS XOH     
222317_at PDE3B XOH  Π = 0.65 (filter1.3) 
209686_at S100B XOH  μA Probeset Gene tests 
211748_x_at PTGDS XOH  209960_at -- XOH 
212013_at Q92626_HUMAN XOH  210755_at -- XOH 
213385_at CHN2 XOH  210997_at HGF XOH 
207996_s_at CS001_HUMAN XOH  220010_at KCNE1L XOH 
209815_at PTCH XOH     
213355_at SIA10_HUMAN XOH     
212012_at Q92626_HUMAN XOH     
219090_at SLC24A3 XOH     
210998_s_at HGF XOH     
211474_s_at SERPINB6 XOH     
212590_at RRAS2 XOH     
212590_at FGF13 -OH     
Table 2. Accuracy of the GCS network trained with selected genes in EXP#1 
Filter Set Mean Std. Err. 
filter1.1 training 0.00% 0.00% 
 test 0.00% 0.00% 
filter1.2 training 0.53% 0.46% 
 test 0.00% 0.00% 
filter1.3 training 1.62% 0.89% 
 test 1.47% 1.27% 
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Table 3. Selected genes in experiment EXP#2 
Π = 0.55 (filter2.1)  Π = 0.60 (filter2.2) 
μA Probeset Gene tests  μA Probeset Gene tests 
220010_at KCNE1L 12/12 220010_at KCNE1L 12/12 
210997_at HGF 12/12 210997_at HGF 12/12 
210755_at -- 12/12 210755_at -- 12/12 
209960_at -- 12/12 209960_at -- 12/12 
207996_s_at CS001_HUMAN 11/12 203074_at ANXA8 11/12 
203074_at ANXA8 11/12 205110_s_at FGF13 8/12 
209560_s_at DLK1 11/12 212187_x_at PTGDS 10/12 
211748_x_at PTGDS 11/12     
213355_at SIA10_HUMAN 10/12     
207781_s_at ZNF6 11/12  Π = 0.65 (filter2.3) 
212912_at RPS6KA2 9/12  μA Probeset Gene tests 
209686_at S100B 10/12  220010_at KCNE1L 11/12 
220570_at RETN 9/12  210997_at HGF 10/12 
211474_s_at SERPINB6 11/12  210755_at -- 9/12 
209815_at PTCH 10/12  209960_at -- 9/12 
205110_s_at FGF13 8/12     
212187_x_at PTGDS 10/12     
208894_at HLA-DRA 10/12     
222317_at PDE3B 8/12     
219090_at SLC24A3 10/12     
213385_at CHN2 10/12     
214617_at PRF1 7/12     
Table 4. Accuracy of the GCS network trained with selected genes in EXP#2 
Filter Set Mean Std. Err. 
Filter2.1 training 0.00% 0.00% 
 test 0.00% 0.00% 
Filter2.2 training 0.00% 0.00% 
 test 0.00% 0.00% 
Filter2.3 training 1.62% 0.89% 
 test 1.47% 1.27% 
5   Results and Conclusions 
Table 1 shows the selected genes in the experiment EXP#1. In this table, the column 
‘tests’ indicates if the gene appears in tests with the same Π value, but different Θ 
value (‘X’ stands for Θ=0.7, ‘O’ for Θ=0.8 and ‘H’ for Θ=0.9). Analyzing these re-
sults, for the value Π=0.55, it has been selected a list with 23 probesets (21 of them 
corresponding to known genes). The list is reduced to 7 probesets when the parameter 
Π is 0.60 and only 4 probesets when Π=0.65. The HGF (Hepatocyte growth factor 
precursor) and KCNE1L (Potassium voltage-gated channel, AMMECR2 protein) 
genes appear in the first positions of the three lists. The HGF gene has been selected 
by PAM software, and its significance has been validated by the biological technique 
qr-PCR, whereas PAM has also detected the KCNE1L gene. The FGF13 gene (Fibro-
blast growth factor 13) also appears as a significant gene when Π=0.55 and Π=0.60. 
The relative relevance of the FGF13 increases when the Θ parameter increases (this  
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gene appears as significant when Π=0.60 for the two higher values of parameter Θ). 
Moreover, this gene has been detected by PAM software and validated by a qr-PCR 
analysis. The S100B, ANXA8 and SLCS24A3 genes have been also selected by PAM 
software, whereas the rest of genes are different. Finally, the three lists of genes (re-
spectively referred to as filter1.1, filter1.2 and filter1.3) have been used to train a GCS 
network. It has been considered the training and test sets of the 4-fold cross validation 
used in EXP#2. The accuracy of the different classifiers is shown in Table 2. 
Table 3 shows the genes selected in the experiment EXP#2. Now, the column 
‘tests’ of the table indicates the number of appearances of a gene in all the possible 
test for the same value of Π. Additionally, the appearances of the same gene in tests 
with a great specificity (a higher value of parameter Θ) weigh more than appearances 
with a lower specificity, when the genes are ranked. As shown in Table 3, the number 
of selected genes is quite similar in the two experiments (there is only a difference of 
one gene among filter1.1 and filter2.1). With regard to the degree of overlapping of 
selected genes in the two experiments, it is also quite similar. The similarity of fil-
ter2.1 with regard to filter1.1 is 19/23=82.6%, the similarity of filter 1.1 with regard 
to filter2.1 is 19/22=86.4%. The degree of overlapping of filter1.2 and filter2.2 is 
6/7=85.7% and, it is a 100% in the case of filter1.3 and filter2.3. Finally, Table 4 
shows the accuracy of the GCS network when it is trained with the selected genes 
(filter2.1, filter2.2 and filter3.3). It is remarkable that filter2.2 has an error of 0% 
predicting novel cases (both within the training set and the test set). 
The experiments carried out, show that the number of genes, which are sufficient 
to correctly classify novel cases, are 7 genes. The genes selected in filter2.2 are es-
pecially remarkable, since with a minimal number of genes (7) it is reached a 100% 
accuracy of the classifier on both training and test sets. The minimal number of 
genes selected by PAM software, which reaches also an accuracy of 100%, was 23 
genes. Therefore, the proposed method has achieved a reduction of the number of 
genes about the 70% with regard to the PAM software (preserving the classifier 
accuracy). 
From Tables 2 and 4, it can be observed that errors on tests sets are always lesser 
than errors on training sets. This can also be interpreted as the selected genes are 
meaningful genes, since they provide an excellent ability of generalization to the 
constructed classifier. 
Finally, from the comparison of similarity among genes selected in the two ex-
periments, we can claim that the proposed method is robust against slight variations 
of the data set from where genes are selected. It is a desirable feature of the algorithm 
in order to select truly meaningful genes. 
Summarizing our work, in this article we have presented and tested a successful 
approach of applying fuzzy logic to the process of gene selection and data reduction 
in the microarray data domain. Our proposed method of fuzzy pattern construction 
takes advantage of the ability inherent to fuzzy logic to process uncertain, imprecise 
and incomplete information. In this sense, we have applied fuzzy logic to discretize 
the original data within the three linguistic labels. This fact leads to the possibility of 
clearly identifying those genes with a great capacity of discriminate patients based on 
the selected genes that compose the discriminant fuzzy patterns. 
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